{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:49:31Z","timestamp":1780411771008,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,11]]},"DOI":"10.7759\/cureus.13820","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T14:01:04Z","timestamp":1615471264000},"source":"Crossref","is-referenced-by-count":7,"title":["Consequences of Diabetes Mellitus in Bone Health: Traditional Review"],"prefix":"10.7759","author":[{"given":"Cheena","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghozlan","family":"Yagoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Ashfaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobia","family":"Jawed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pousette","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0155","article-title":"Management of endocrine disease: diabetes and osteoporosis: cause for concern?","volume":"173","author":"Starup-Linde J","year":"2015","unstructured":"Starup-Linde J, Vestergaard P. Management of endocrine disease: diabetes and osteoporosis: cause for concern?. Eur J Endocrinol. 2015, 173:93-99. 10.1530\/EJE-15-0155","journal-title":"Eur J Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10412","article-title":"The future of metformin in the prevention of diabetes-related osteoporosis","volume":"12","author":"Aung M","year":"2020","unstructured":"Aung M, Amin S, Gulraiz A, Gandhi FR, Pena Escobar JA, Malik BH. The future of metformin in the prevention of diabetes-related osteoporosis. Cureus. 2020, 12:e10412. 10.7759\/cureus.10412","journal-title":"Cureus"},{"key":"ref3","unstructured":"IDF Diabetes Atlas, 9th edition. (2019). Accessed. March 8, 2021: https:\/\/www.diabetesatlas.org\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli N","year":"2017","unstructured":"Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari AL. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017, 13:208-219. 10.1038\/nrendo.2016.153","journal-title":"Nat Rev Endocrinol"},{"key":"ref5","article-title":"Prevalence of osteoporosis in patients with type 2 diabetes mellitus in the Chinese mainland: a systematic review and meta-analysis","volume":"48","author":"Si Y","year":"2019","unstructured":"Si Y, Wang C, Guo Y, Xu G, Ma Y. Prevalence of osteoporosis in patients with type 2 diabetes mellitus in the Chinese mainland: a systematic review and meta-analysis. Iran J Pub Health. 2019, 48:1203-1214.","journal-title":"Iran J Pub Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1344-9","article-title":"Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database","volume":"17","author":"Sato M","year":"2016","unstructured":"Sato M, Ye W, Sugihara T, Isaka Y. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database. BMC Musculoskelet Disord. 2016, 17:489. 10.1186\/s12891-016-1344-9","journal-title":"BMC Musculoskelet Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024067","article-title":"Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis","volume":"9","author":"Wang H","year":"2019","unstructured":"Wang H, Ba Y, Xing Q, Du JL. Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open. 2019, 9:e024067. 10.1136\/bmjopen-2018-024067","journal-title":"BMJ Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0905-18","article-title":"Diabetes mellitus-induced bone fragility","volume":"57","author":"Kanazawa I","year":"2018","unstructured":"Kanazawa I, Sugimoto T. Diabetes mellitus-induced bone fragility. Intern Med. 2018, 57:2773-2785. 10.2169\/internalmedicine.0905-18","journal-title":"Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2019.231","article-title":"Osteoporosis and fracture risk in patients with type 2 diabetes mellitus","volume":"15","author":"Poiana C","year":"2019","unstructured":"Poiana C, Capatina C. Osteoporosis and fracture risk in patients with type 2 diabetes mellitus. Acta Endocrinol (Buc). 2019, 15:231-236. 10.4183\/aeb.2019.231","journal-title":"Acta Endocrinol (Buc)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2004.09.014","article-title":"High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes","volume":"54","author":"Yoshida N","year":"2005","unstructured":"Yoshida N, Okumura K, Aso Y. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism. 2005, 54:345-350. 10.1016\/j.metabol.2004.09.014","journal-title":"Metabolism"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)99006-X","article-title":"Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors","volume":"266","author":"Grandhee SK","year":"1991","unstructured":"Grandhee SK, Monnier VM. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J Biol Chem. 1991, 266:11649-11653. 10.1016\/S0021-9258(18)99006-X","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and management of bone fragility in diabetes: an emerging challenge","volume":"29","author":"Ferrari SL","year":"2018","unstructured":"Ferrari SL, Abrahamsen B, Napoli N, et al.. Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int. 2018, 29:2585-2596. 10.1007\/s00198-018-4650-2","journal-title":"Osteoporos Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2106","article-title":"In vivo assessment of bone quality in postmenopausal women with type 2 diabetes","volume":"29","author":"Farr JN","year":"2014","unstructured":"Farr JN, Drake MT, Amin S, et at.. In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res. 2014, 29:787-795. 10.1002\/jbmr.2106","journal-title":"J Bone Miner Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00021","article-title":"Diabetes, biochemical markers of bone turnover, diabetes control, and bone","volume":"4","author":"Starup-Linde J","year":"2013","unstructured":"Starup-Linde J. Diabetes, biochemical markers of bone turnover, diabetes control, and bone. Front Endocrinol. 2013, 4:21. 10.3389\/fendo.2013.00021","journal-title":"Front Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/421746","article-title":"Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells","volume":"421746","author":"Florencio-Silva R","year":"2015","unstructured":"Florencio-Silva R, Sasso GR, Sasso-Cerri E, et at.. Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. BioMed Res Int. 2015, 421746:10.1155\/2015\/421746","journal-title":"BioMed Res Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle J","year":"2017","unstructured":"Delgado-Calle J, Sato AY, Bellido T. Role and mechanism of action of sclerostin in bone. Bone. 2017, 96:29-37. 10.1016\/j.bone.2016.10.007","journal-title":"Bone"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4269-4","article-title":"Diabetes, bone and glucose-lowering agents: basic biology","volume":"60","author":"Lecka-Czernik B","year":"2017","unstructured":"Lecka-Czernik B. Diabetes, bone and glucose-lowering agents: basic biology. Diabetologia. 2017, 60:1163-1169. 10.1007\/s00125-017-4269-4","journal-title":"Diabetologia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2013.12.055","article-title":"Thoracic spine fracture in the course of severe nocturnal hypoglycemia in young patients with type 1 diabetes mellitus - the role of low bone mineral density","volume":"816","author":"Majkowska L","year":"2014","unstructured":"Majkowska L, Wali\u0142ko E, Mole\u02dbda P, Bohatyrewicz A. Thoracic spine fracture in the course of severe nocturnal hypoglycemia in young patients with type 1 diabetes mellitus - the role of low bone mineral density. Am J Emerg Med. 2014, 816:5-7. 10.1016\/j.ajem.2013.12.055","journal-title":"Am J Emerg Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet B","year":"2012","unstructured":"Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci. 2012, 122:253-270. 10.1042\/CS20110386","journal-title":"Clin Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01461.x","article-title":"A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone\/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-na\u00efve type 2 diabetes mellitus patients","volume":"13","author":"Borges JL","year":"2011","unstructured":"Borges JL, Bilezikian JP, Jones-Leone AR, et al.. A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone\/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-na\u00efve type 2 diabetes mellitus patients. Diabetes Obes Metab. 2011, 13:1036-1046. 10.1111\/j.1463-1326.2011.01461.x","journal-title":"Diabetes Obes Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i18.4010","article-title":"Effects of different doses of metformin on bone mineral density and bone metabolism in elderly male patients with type 2 diabetes mellitus","volume":"8","author":"Wang LX","year":"2020","unstructured":"Wang LX, Wang GY, Su N, Ma J, Li YK. Effects of different doses of metformin on bone mineral density and bone metabolism in elderly male patients with type 2 diabetes mellitus. World J Clin Cases. 2020, 8:4010-4016. 10.12998\/wjcc.v8.i18.4010","journal-title":"World J Clin Cases"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1188","article-title":"High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study","volume":"36","author":"Oei L","year":"2013","unstructured":"Oei L, Zillikens MC, Dehghan A, et al.. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care. 2013, 36:1619-1628. 10.2337\/dc12-1188","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107990","article-title":"Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis","volume":"159","author":"Zhang Z","year":"2020","unstructured":"Zhang Z, Cao Y, Tao Y, et al.. Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis. Diabetes Res Clin Pract. 2020, 159:107990. 10.1016\/j.diabres.2019.107990","journal-title":"Diabetes Res Clin Pract"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.11.026","article-title":"Use of glucose-lowering drugs and risk of fracture in patients with type 2 diabetes","volume":"95","author":"Starup-Linde J","year":"2017","unstructured":"Starup-Linde J, Gregersen S, Frost M, Vestergaard P. Use of glucose-lowering drugs and risk of fracture in patients with type 2 diabetes. Bone. 2017, 95:136-142. 10.1016\/j.bone.2016.11.026","journal-title":"Bone"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194873","article-title":"Impact of diabetes mellitus on bone health","volume":"20","author":"Murray CE","year":"2019","unstructured":"Murray CE, Coleman CM. Impact of diabetes mellitus on bone health. Int J Mol Sci. 2019, 20:4873. 10.3390\/ijms20194873","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v10.i8.421","article-title":"Bone health in diabetes and prediabetes","volume":"10","author":"Costantini S","year":"2019","unstructured":"Costantini S, Conte C. Bone health in diabetes and prediabetes. World J Diabetes. 2019, 10:421-445. 10.4239\/wjd.v10.i8.421","journal-title":"World J Diabetes"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1197","article-title":"Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures","volume":"27","author":"Kurra S","year":"2011","unstructured":"Kurra S, Siris E.. Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures. Diabetes Metab Res Rev. 2011, 27:430-435.  10.1002\/dmrr.1197","journal-title":"Diabetes Metab Res Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0361-4","article-title":"Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials","volume":"48","author":"Su B","year":"2015","unstructured":"Su B, Sheng H, Zhang M, et al.. Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials. Endocrine. 2015, 48:107-115. 10.1007\/s12020-014-0361-4","journal-title":"Endocrine"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.110296","article-title":"Sergliflozin, a novel selective inhibitor of low-affinity sodium-glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level","volume":"320","author":"Katsuno K","year":"2007","unstructured":"Katsuno K, Fujimori Y, Takemura Y, et al.. Sergliflozin, a novel selective inhibitor of low-affinity sodium-glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level. J Pharmacol Exp Ther. 2007, 320:323-330.  10.1124\/jpet.106.110296","journal-title":"J Pharmacol Exp Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00388.2010","article-title":"Glucose transport by human renal Na+\/D-glucose cotransporters SGLT1 and SGLT2","volume":"300","author":"Hummel CS","year":"2011","unstructured":"Hummel CS, Lu C, Loo DDF, Hirayama BA, Voss AA, Wright EM. Glucose transport by human renal Na+\/D-glucose cotransporters SGLT1 and SGLT2. Am J Physiol Cell Physiol. 2011, 300:14-21. 10.1152\/ajpcell.00388.2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1615735","article-title":"Fracture risk in type 2 diabetes: current perspectives and gender differences","volume":"2016","author":"Russo GT","year":"2016","unstructured":"Russo GT, Giandalia A, Romeo EL, et al.. Fracture risk in type 2 diabetes: current perspectives and gender differences. Int J Endocrinol. 2016, 2016:1615735. 10.1155\/2016\/1615735","journal-title":"Int J Endocrinol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1860","article-title":"Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin","volume":"101","author":"Bilezikian JP","year":"2016","unstructured":"Bilezikian JP, Watts NB, Usiskin K, Polidori D, Fung A, Sullivan D, Rosenthal N. Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin. J Clin Endocrinol Metab. 2016, 101:44-51. 10.1210\/jc.2015-1860","journal-title":"J Clin Endocrinol Metab"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2015.06.001","article-title":"Bone defect regeneration and cortical bone parameters of type 2 diabetic rats are improved by insulin therapy","volume":"82","author":"Picke AK","year":"2016","unstructured":"Picke AK, Gordaliza Alaguero I, Campbell GM, et al.. Bone defect regeneration and cortical bone parameters of type 2 diabetic rats are improved by insulin therapy. Bone. 2016, 82:108-115.  10.1016\/j.bone.2015.06.001","journal-title":"Bone"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2017.06.011","article-title":"Fracture risk assessment in patients with diabetes mellitus","volume":"20","author":"Poiana C","year":"2017","unstructured":"Poiana C, Capatina C. Fracture risk assessment in patients with diabetes mellitus. J Clin Densitom. 2017, 20:432-443. 10.1016\/j.jocd.2017.06.011","journal-title":"J Clin Densitom"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/44228-consequences-of-diabetes-mellitus-in-bone-health-traditional-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:58Z","timestamp":1707507058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/44228-consequences-of-diabetes-mellitus-in-bone-health-traditional-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.13820","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,11]]}}}